APOBEC3B and neoplasm: Furthermore, APOBEC3B promotes the upregulation of chemokine expression, leading to the recruitment of myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs), which inhibit CD8+ T cell function and create an immunosuppressive microenvironment conducive to liver cancer development (26).